View of AI-Driven Precision Targeting Beyond KRAS: Daraxonrasib, Pan-RAS(ON) Inhibition, and Emerging Predictive Biomarkers in RAS-Driven Cancers

Return to Article Details AI-Driven Precision Targeting Beyond KRAS: Daraxonrasib, Pan-RAS(ON) Inhibition, and Emerging Predictive Biomarkers in RAS-Driven Cancers Download Download PDF